137 results on '"REMVIKOS Y"'
Search Results
2. Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis
3. Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancer
4. Santé et cadre de vie : résultats d’une approche sociologique sur le vécu des habitants de quartiers populaires
5. HRT and breast cancer
6. Ganglion sentinelle et cancer opérable du sein : utilisation du bleu patent. Étude pilote
7. Prognostic value of epidermal growth factor receptor in node-positive breast cancer
8. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis
9. Survival and acquired genetic alterations in colorectal cancer
10. Multiple genetic alterations in distal and proximal colorectal cancer
11. Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.
12. Apports de la génétique en gastroentérologie. Les progrès en génétique ont-ils changé la prise en charge thérapeutique des cancers colorectaux?
13. Correlations between p53 overexpression, serum antibodies and gene mutation in colorectal cancer
14. The p53-positive phenotype of breast cancers
15. S-phase fractions of breast cancer predict overall and post-relapse survival
16. Colorectal carcinogenesis: From chromosomal evolution pathways to molecular pathogenesis
17. Gene amplification and TP53 mutations in an experimental model of colorectal cancer
18. PP-6-19 Pre-Operative Diagnosis and Establishment of Breast Cancer Phenotypic Features of Prognostic Relevance on Routine Fine-Needle Cytological Samples
19. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
20. Prognostic Value of the S-Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy
21. Prognostic value of the S-phase fraction of breast cancer
22. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates
23. Increased p53 protein content of colorectal tumours correlates with poor survival
24. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation
25. DNA content analysis by flow cytometry in hepatocellular carcinoma (HCC)
26. Studies on the Influence of the Presence of an ActivatedRasOncogene on thein VitroRadiosensitivity of Human Mammary Epithelial Cells
27. Simultaneous monitoring of P53 protein and dna content of colorectal adenocarcinomas by flow cytometry
28. A simplified immuno‐enzymetric assay of the epidermal growth factor receptor in breast tumors: Evaluation in 282 cases
29. DNA flow cytometry of breast cancer fine needle aspirates
30. DNA content and genetic evolution of human colorectal adenocarcinoma. A study by flow cytometry and cytogenetic analysis.
31. Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas.
32. DNA flow cytometry applied to fine needle sampling of human breast cancer.
33. Studies on the Influence of the Presence of an Activated Ras Oncogene on the in Vitro Radiosensitivity of Human Mammary Epithelial Cells.
34. Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy.
35. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation
36. Relevance of DNA ploidy as a measure of genetic deviation: A comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer
37. Characterization of a new cytogenetic subtype of ductal breast carcinomas.
38. Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas.
39. [Sentinel node and operable breast cancer: utilization of blue dye injection. Pilot study].
40. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer.
41. Distinct chromosomal alterations associated with TP53 status of LoVo cells under PALA selective pressure: a parallel with cytogenetic pathways of colorectal cancers.
42. [Contributions of genetics in gastroenterology. Has genetic progress changed the therapeutic management of colorectal neoplasms? "Colon" Group of the Curie Institute].
43. Assessing genetic markers of tumour progression in the context of intratumour heterogeneity.
44. Quantification and characterization of total cellular p53 protein in colorectal cancer.
45. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
46. DNA-repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements.
47. Genetic evolution of breast cancers. III: Age-dependent variations in the correlations between biological indicators of prognosis.
48. [Two colons--two cancers? Proximal or distal adenocarcinoma: arguments for a different carcinogenesis].
49. [Genetic abnormalities in colorectal cancer].
50. [Genetic anomalies of colorectal cancers].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.